Junjie Yang
5PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|May 31, 2022
Scaffold Hopping Strategy to Identify Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy.Wei Wang, Jiacheng He, Junjie Yang
|Feb 25, 2022
A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer Metastasis.Jiacheng He, Xianhua Lin, Fanhui Meng
|Nov 06, 2021
Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy.Shihong Peng, Pan Hu, Yu-Tian Xiao
|Dec 31, 2020
From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis.Bei-Er Jiang, Xingwu Jiang, Qiansen Zhang
|Dec 20, 2019
Discovery and Characterization of 1H-1,2,3-Triazole Derivatives as Novel Prostanoid EP4 Receptor Antagonists for Cancer Immunotherapy.Jun-Jie Yang, Wei-Wei Yu, Long-Long Hu
Pageof 1
Frequent Collaborators
4 joint publications
Mingyao Liu
4 joint publications
Weiqiang Lu
3 joint publications
Qiansen Zhang
3 joint publications
Han-Kun Zhang
2 joint publications
Peili Wang
1 joint publications
Li-Fang Yu
1 joint publications
Yu-Tian Xiao
1 joint publications
Jiacheng He
1 joint publications
Wei Wang
1 joint publications
Zhiyuan Cheng
